TSE:VBV VBI Vaccines (VBV) Stock Price, News & Analysis → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free VBV Stock Alerts C$4.82 -0.26 (-5.12%) (As of 03/23/2018) Add Share Share Today's RangeC$4.82▼C$5.0550-Day Range N/A52-Week RangeC$3.85▼C$7.60Volume1,300 shsAverage Volume3,637 shsMarket CapitalizationC$308.86 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get VBI Vaccines alerts: Email Address Ad InvestorPlaceElon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About VBI Vaccines Stock (TSE:VBV)VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus. It is also developing congenital cytomegalovirus vaccine candidate for infectious disease; and therapeutic glioblastoma multiforme vaccine candidate for immuno-oncology. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS.Read More VBV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VBV Stock News HeadlinesApril 16, 2024 | msn.comVBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023October 31, 2023 | morningstar.comVBI Vaccines Inc VBIVApril 29, 2024 | InvestorPlace (Ad)Elon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” September 26, 2023 | usatoday.comNo, Pfizer COVID-19 vaccine doesn't cause 'VAIDS.' That's not a real condition | Fact checkSeptember 23, 2023 | usatoday.comUpdated COVID-19 vaccine recommended for everyone; old, young, immunocompromised will benefit mostSeptember 21, 2023 | nypost.comThe real data behind the new COVID vaccines the White House is pushingSeptember 15, 2023 | nypost.comCOVID vaccine pill that kills virus before it infects the body could be comingAugust 30, 2023 | foxnews.comBiden plans to ask Congress for funding to develop new COVID vaccine, may recommend shot for allApril 29, 2024 | InvestorPlace (Ad)Elon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” July 6, 2023 | msn.comVBI Vaccines slides on discounted stock and warrants offeringJuly 5, 2023 | marketwatch.comVBI Vaccines Shares Turn Lower, Erase After-Hours GainsJune 7, 2023 | msn.comVBI Vaccines gains ahead of upcoming presentation on hep B shotMay 15, 2023 | msn.comVBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Misses Revenue EstimatesApril 14, 2023 | msn.comRaymond James Maintains VBI Vaccines (VBIV) Outperform RecommendationApril 5, 2023 | marketwatch.comVBI Vaccines to Cut Workforce by 30%-35%, Focus on Hepatitis B >VBIVApril 5, 2023 | marketwatch.comVBI Vaccines Shares Plumb New Depths on Restructuring Plans >VBIVApril 4, 2023 | msn.comVBI Vaccines to focus on hep B treatments, conduct 1-for-30 reverse stock splitMarch 30, 2023 | nypost.comHow mRNA vaccines could target everything from cancer to the plagueMarch 28, 2023 | nbcnews.comModerna CEO grilled over plan to raise Covid vaccine price at Senate hearingMarch 15, 2023 | usatoday.comPeople without insurance will still get free COVID vaccines once government's supply runs outMarch 14, 2023 | theguardian.comFlorida surgeon general’s Covid vaccine claims harm public, health agencies sayMarch 13, 2023 | foxnews.comLA County eases COVID vaccine, testing restrictions as emergency declarations endFebruary 24, 2023 | cnbc.comFlu vaccine was 68% effective at preventing hospitalization in children but less protective for seniors this seasonFebruary 22, 2023 | reuters.comDevelop vaccines for all animal influenza strain, says incoming WHO chief scientistFebruary 22, 2023 | foxnews.comPrior COVID infection provides just as much protection as vaccines, new study findsFebruary 20, 2023 | usnews.comTwo Vaccines May Soon Shield Seniors Against RSVFebruary 15, 2023 | marketwatch.comThe Rise of Virus-like Particles (VLPs) Vaccine Market Research 2023-2029: Opportunities and ChallengesSee More Headlines Receive VBV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolTSE:VBV CUSIPN/A CIKN/A Webwww.vbivaccines.com Phone+1-617-8303031FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio14.29 Current Ratio2.64 Quick Ratio2.54 Sales & Book Value Annual SalesC$3.36 million Price / Sales92.06 Cash FlowN/A Price / Cash FlowN/A Book ValueC$1.01 per share Price / Book4.78Miscellaneous Outstanding Shares64,079,000Free FloatN/AMarket CapC$308.86 million OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Jeff R. Baxter (Age 57)CEO, Pres & Director Dr. David Evander Anderson Ph.D. (Age 48)Chief Scientific Officer Ms. Athena Kartsaklis (Age 53)Sr. VP of Fin., Principal Financial & Accounting Officer, Chief Compliance Officer Ms. Nell Beattie (Age 30)Chief Bus. Officer Dr. Francisco Diaz-Mitoma M.D. (Age 63)Ph.D., Chief Medical Officer VBV Stock Analysis - Frequently Asked Questions How have VBV shares performed in 2024? VBI Vaccines' stock was trading at C$4.82 at the beginning of 2024. Since then, VBV stock has increased by 0.0% and is now trading at C$4.82. View the best growth stocks for 2024 here. What other stocks do shareholders of VBI Vaccines own? Based on aggregate information from My MarketBeat watchlists, some companies that other VBI Vaccines investors own include Teladoc Health (TDOC), PhaseBio Pharmaceuticals (PHAS), Amarin (AMRN), Adverum Biotechnologies (ADVM), Assertio (ASRT), Activision Blizzard (ATVI), Axsome Therapeutics (AXSM), Boeing (BA), Beyond Meat (BYND) and Cardlytics (CDLX). How do I buy shares of VBI Vaccines? Shares of VBV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:VBV) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VBI Vaccines Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
